UK markets close in 3 hours 48 minutes

genedrive plc (GDR.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
3.1550-0.0950 (-2.92%)
As of 12:22PM GMT. Market open.

genedrive plc

The CTF Building
48 Grafton Street
Manchester M13 9XX
United Kingdom
44 16 1989 0245
https://www.genedriveplc.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees43

Key executives

NameTitlePayExercisedYear born
Mr. Russell John ShawCFO, Secretary & Director158.08kN/A1978
Mr. James CheekCEO & DirectorN/AN/A1967
Dr. Gino MieleChief Scientific Officer & Executive DirectorN/AN/A1970
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings. It also offers Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

Corporate governance

genedrive plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.